《市評》恆指止連跌 北水轉淨流入 醫藥股起舞
恆指「三連跌」(累跌831點或3.2%)後,今日(29日)反覆回升。市場持續關注美聯儲局理事庫克遭美總統特朗普解僱事件,美股道指及納指隔晚(28日)各升0.2%及0.5%,市場觀望美國今晚公佈7月PCE物價指數,撰文之時,美國2年期債券孳息升至3.637%,美國10年期債券孳息跌至4.23%,美匯指數跌至97.93,道指期貨最新跌166點或0.4%,納指期貨最新跌115點或0.5%。上證綜指全日升14點或0.37%收3,857點,深證成指收升近1%,內地創業板指數升2.2%,滬深兩市成交額共近2.8萬億元人民幣。
恆指高開96點後升幅擴大,曾升278點一度高見25,277點,全日升78點或0.3%,收25,077點;國指升30點或0.35%,收8,947點;恆生科技指數升30點或0.5%,收5,674點。大市全日成交總額3,356.01億元。北水交易總成交額1,809.01億元,而南向資金今日淨流入120.46億元(上日淨流出204.41億元)。科技股方面,阿里-W(09988.HK)收市後公佈業績,股價微跌0.1%收115.7元,美團(03690.HK)升近1%。
恆指本週累跌261點或1%、國指本週累跌132點或1.5%、恆生科指本週累升26點或0.5%,南向資本週淨流入221.72億元(上週淨流入179.04億元)。恆指8月累升304點或1.2%、國指8月累升64點或0.7%、恆生科指8月累升221點或近4.1%),而南向資8月淨流入1,121.56億元(7月淨流入1,356.48億元)。
【北水轉淨流入 醫藥股起舞】
醫藥股再現炒作,榮昌生物(09995.HK)全日股價彈11.5%,綠葉(02186.HK)、藥明生物(02269.HK)、信達生物(01801.HK)、石藥(01093.HK)及藥明康德(02359.HK)升6.5%至7.8%,中生製藥(01177.HK)及恆瑞(01276.HK)升5.5%及4.9%。和鉑醫藥(02142.HK)擬折讓9.5%配股,淨籌5.12億元,該股升15.9%,成交4.73億元。主打AI藥物發現的晶泰(02228.HK)擬折讓7.8%配股淨籌26.3億,上半年扭虧爲盈,股價收升2.5%。
中銀香港(02388.HK)全日股價走低2.7%收35.22元。中銀香港收市後公佈今年中期業績,提取減值準備前淨經營收入400.22億元按年升13.3%。純利221.52億元,按年升10.5%;每股盈利2.0952元。派第二次中期股息每股0.29元,上年同期派息0.57元。
中銀香港上半年淨利息收入爲250.63億元,按年跌3.5%。淨息差爲1.34%,去年同期爲淨息差爲1.46%。另外,總資本比率爲25.69%;普通股權一級資本比率及一級資本比率均爲23.69%。該行上半年貸款及其他賬項減值準備淨撥備爲32.64億元,按年增加57.9%。該行指,與2024年下半年相比,貸款及其他賬項減值準備淨撥備增加3.86億元,主要是2025年上半年貸款增長,以及商業房地產仍然疲弱,加上全球貿易局勢令宏觀前景不確定性增加,更新預期信用損失模型參數,對受影響客戶作審慎增提撥備。而中銀香港上半年減值準備淨撥備爲33.18億人民幣按年升59.4%,瑞銀上月底報告估計減值準備淨撥備爲30.28億元。
【上升股千一隻 穩定幣概念彈】
港股今日市寬改善,主板股票的升跌比率爲27比24(上日爲14比38),上升股份1,100只(升幅3.4%),恆指成份股今日52只股份上升,下跌股份32只,升跌比率爲61比38(上日12比87)。大市今日錄沽空497.52億元,佔可沽空股份成交額3,106.06億元的16.018%(上日爲17.777%)。
穩定幣概念再熱炒,衆安在線(06060.HK)全日股價搶高3.4%。國泰君安國際(01788.HK)宣佈在港推加密貨幣交易服務。股價升15.7%收5.9元,成交66.6億元。
國泰君安國際宣佈正式爲香港投資者推出加密貨幣交易服務,以滿足香港投資者對加密貨幣市場日益增長的需求。公司指,客戶開通加密貨幣賬戶後,可立即交易不同的加密貨幣,包括比特幣(BTC)、以太幣(ETH)、雪崩幣(AVAX)、Chainlink(LINK)及Solana(SOL)等。具備專業投資者資格的客戶更可選擇進階投資標的,包括瑞波幣(XRP)、泰達(USDT)及美元穩定幣(USDC)等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.